Business Description
Nipro Corp
ISIN : JP3673600007
Share Class Description:
NPRRF: Ordinary SharesTotal Employee Number:
40,590Description
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm is divided into three segment: Medical segment sells medical devices related to injections and infusions, artificial organs, high-performance devices, and dialysis, as well as pharmaceuticals related to diabetes, generics, and kit formulations in Japan and overseas; Pharmaceutical segment handles the consignment sales of pharmaceuticals from pharmaceutical companies, including containers for kit formulations; and Pharmaceutical Packaging handles glass for medical use in Japan, including glass for vials and ampoules, and glassware. Nipro generates the majority of its revenue in Japan, while it also has its presence in America, Europe and Asia.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | 0.23 | |||||
Debt-to-Equity | 2.34 | |||||
Debt-to-EBITDA | 6.23 | |||||
Interest Coverage | 3.85 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.12 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EBITDA Growth Rate | 13.7 | |||||
3-Year EPS without NRI Growth Rate | 30.1 | |||||
3-Year Book Growth Rate | 9.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 21.44 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
6-1 Month Momentum % | 21.02 | |||||
12-1 Month Momentum % | 21.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.39 | |||||
Quick Ratio | 0.77 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 207.36 | |||||
Days Sales Outstanding | 91.27 | |||||
Days Payable | 67.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 9.6 | |||||
Shareholder Yield % | 5.92 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 31.53 | |||||
Operating Margin % | 5.7 | |||||
Net Margin % | 2.04 | |||||
EBITDA Margin % | 15.59 | |||||
FCF Margin % | -1.11 | |||||
OCF Margin % | 7.91 | |||||
ROE % | 5.36 | |||||
ROA % | 1.15 | |||||
ROIC % | 2.12 | |||||
3-Year ROIIC % | 9.05 | |||||
ROC (Joel Greenblatt) % | 4.96 | |||||
ROCE % | 4.99 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 21.4 | |||||
Forward PE Ratio | 16.6 | |||||
PE Ratio without NRI | 37.81 | |||||
Shiller PE Ratio | 31.74 | |||||
PEG Ratio | 5.18 | |||||
PS Ratio | 0.44 | |||||
PB Ratio | 0.93 | |||||
Price-to-Tangible-Book | 1.15 | |||||
Price-to-Operating-Cash-Flow | 5.29 | |||||
EV-to-EBIT | 21.91 | |||||
EV-to-EBITDA | 8.35 | |||||
EV-to-Revenue | 1.3 | |||||
EV-to-FCF | -112.07 | |||||
Price-to-GF-Value | 1.07 | |||||
Price-to-Projected-FCF | 0.38 | |||||
Price-to-Median-PS-Value | 0.94 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.51 | |||||
Price-to-Graham-Number | 1.39 | |||||
Earnings Yield (Greenblatt) % | 4.56 | |||||
FCF Yield % | -3 | |||||
Forward Rate of Return (Yacktman) % | 24.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NPRRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nipro Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4,353.185 | ||
| EPS (TTM) ($) | 0.487 | ||
| Beta | -0.3049 | ||
| 3-Year Sharpe Ratio | 0.14 | ||
| 3-Year Sortino Ratio | 0.72 | ||
| Volatility % | 22.4 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR ($) | 0.00005 | ||
| 20-Day SMA ($) | 9.96 | ||
| 12-1 Month Momentum % | 21.02 | ||
| 52-Week Range ($) | 8.23 - 9.96 | ||
| Shares Outstanding (Mil) | 163.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nipro Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nipro Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| JPY 12.000000 Cash Dividend | 2026-09-29 | In 55 days | ||
| JPY 19.000000 Cash Dividend | 2026-03-30 | 9.96 (+0.00%) | ||
| JPY 10.000000 Cash Dividend | 2025-09-29 | 8.23 (+0.00%) | ||
| JPY 13.000000 Cash Dividend | 2025-03-28 | 8.23 (+0.00%) | ||
| JPY 12.000000 Cash Dividend | 2024-09-27 | 8.50 (+0.00%) | ||
| 2:1 Stock Split | 2011-09-28 | -- |
Show
Entries
Nipro Corp Frequently Asked Questions
What is Nipro Corp(NPRRF)'s stock price today?
The current price of NPRRF is $9.96. The 52 week high of NPRRF is $9.96 and 52 week low is $8.23.
When is next earnings date of Nipro Corp(NPRRF)?
The next earnings date of Nipro Corp(NPRRF) is .
Does Nipro Corp(NPRRF) pay dividends? If so, how much?
Nipro Corp(NPRRF) does not pay dividend.
Guru Commentaries on OTCPK:NPRRF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers